We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ultrafast Laser Technology to Improve Cancer Treatment

By HospiMedica International staff writers
Posted on 19 Dec 2023

Ultrafast laser technology continues to reveal its potential, especially in the field of healthcare. More...

While the study of high-power laser pulses might seem theoretical, it often translates into practical applications, such as in cancer treatment. This was highlighted in a recent study that challenges some long-held beliefs in the scientific community about the capabilities of these lasers.

Traditionally, it was understood that focusing a high-intensity laser pulse in ambient air would create plasma at the focus point, generating electrons with a maximum energy of a few keV (kiloelectronvolts). However, surpassing this energy level in ambient air was considered unfeasible due to physical constraints. A research team at the Institut national de recherche scientifique (INRS, Québec City, Canada) has now shown that electrons accelerated in ambient air can achieve energies in the MeV (megaelectronvolts) range, approximately 1000 times higher than previously thought possible.

This significant advancement paves the way for major developments in medical physics. A notable application is in FLASH radiotherapy, an innovative method for treating tumors that are unresponsive to standard radiation therapy. FLASH radiotherapy delivers high doses of radiation extremely quickly (microseconds instead of minutes), better safeguarding the surrounding healthy tissue. The precise mechanism behind the FLASH effect, which seems to involve a swift deoxygenation of healthy tissues thereby reducing their sensitivity to radiation, is still not fully understood. The implications of this discovery are twofold. Firstly, it highlights the need for increased caution when handling tightly focused laser beams in ambient air. Secondly, measurements taken near the source revealed an electron radiation dose rate three to four times higher than what is used in conventional radiation therapy.

“No study has been able to explain the nature of the FLASH effect. However, the electron sources used in FLASH radiotherapy have similar characteristics to the one we produced by focusing our laser strongly in ambient air,” said  Simon Vallières, postdoctoral researcher and first author of the study. “Once the radiation source is better controlled, further research will allow us to investigate what causes the FLASH effect and to, ultimately, offer better radiation treatments to cancer patients.”

Related Links:
INRS


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.